NATO Drone Edge Initiative: Geopolitical Context, Technological Dimension, and Challenges for Russia
Analytical papers of the Institute of Europe RAS · 2026 · (3) · 20-27
DOI: 10.15211/analytics33020262027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical papers of the Institute of Europe RAS, 2026. Verfasst von Sergey Grinyaev.
Abstract (Originalsprache)
The article analyzes NATO Drone Edge initiative, announced at Ankara summit on July 7, 2026 as a result of the alliance's accumulated military-political and military-technical conclusions from the conflict in Ukraine. The author examines geopolitical prerequisites for launching the initiative, the role of unmanned systems in modern conflict, changes in the regulatory framework and military construction of NATO countries, as well as the technical and technological foundations of the new program. Special attention is paid to the role of the Ukrainian military-industrial complex as a channel for transferring combat experience to the European and American defense industries. It is concluded that Drone Edge means the transition of NATO to a more holistic model of collective adaptation in the field of unmanned and counter-unmanned systems and creates long-term military and strategic challenges for Russia.
Zitieren
APA
Grinyaev, S. (2026). NATO Drone Edge Initiative: Geopolitical Context, Technological Dimension, and Challenges for Russia. Analytical papers of the Institute of Europe RAS, 20-27. https://doi.org/10.15211/analytics33020262027
Vancouver
Grinyaev S. NATO Drone Edge Initiative: Geopolitical Context, Technological Dimension, and Challenges for Russia. Analytical papers of the Institute of Europe RAS. 2026:20-27. doi:10.15211/analytics33020262027
BibTeX
@article{Grinyaev2026,
author = {Grinyaev, Sergey},
title = {NATO Drone Edge Initiative: Geopolitical Context, Technological Dimension, and Challenges for Russia},
journal = {Analytical papers of the Institute of Europe RAS},
year = {2026},
number = {3},
pages = {20--27},
doi = {10.15211/analytics33020262027}
}
EUVIMED